Learning Objectives:

• Recognize and diagnose hypertrophic cardiomyopathy.
• Identify phenocopies of hypertrophic cardiomyopathy.
• Learn contemporary treatment strategies for hypertrophic cardiomyopathy.

Robby Wu, DO (he/him/his), Advanced Heart Failure and Transplant Cardiologist, University of South Florida and Tampa General Hospital

Learning Objectives:

• Identify current screening and diagnostic tests in evaluating a patient with kidney disease
• Discuss the pathophysiology and cardiovascular comorbidity in chronic kidney disease and the effect of lifestyle modification in the treatment of chronic kidney disease.
• Review current individualized pharmacological treatments to slow the progression of chronic kidney disease and the associated metabolic complications.

Mark D. Baldwin, DO, MACOI, FASN (he/him/his), Professor of Internal Medicine, Nephrology & Hypertension, ACOI

Learning Objectives:

• Explain how the body handles and excretes the daily acid load
• Define a renal tubular acidosis
• Describe the causes and diagnostic criteria for a Type I Distal, Type II Proximal, and Type IV Distal Renal Tubular Acidosis

Mark D. Baldwin, DO, MACOI, FASN (he/him/his), Professor of Internal Medicine, Nephrology & Hypertension, ACOI

Learning Objectives:

• Recognize AKI as a common and high-mortality complication in hospitalized patients
• Apply standardized diagnostic criteria (RIFLE, AKIN, KDIGO) for early identification of AKI
• Differentiate prerenal, intrinsic, and postrenal causes of AKI using clinical and laboratory findings. Identify high risk patient populations and common hospital acquired contributors to AKI Implement evidence-based strategies for prevention, evaluation, and management of AKI in the inpatient setting

Anis Rauf, DO, Physician, NANI

Learning Objectives:

• Upon completion, participant will be able to: 
  • Recognize the epidemiology and clinical phenotypes of GCA.
  • Outline diagnostic workup (labs, imaging, biopsy) for inpatient GCA.
  • Initiate acute management of GCA and mitigate steroid toxicity in the inpatient setting.

Priyanka A. Murali, DO, FACOI, Rheumatology Site Director, C.W. Bill Young VA Medical Center

60 minutes

Learning Objectives:

• Explain the physiology of normal sleep and analyze how sleep disruption impacts healing and recovery in hospitalized patients.
• Identify and apply appropriate screening tools to detect sleep apnea risk in hospitalized patients.
• Formulate evidence-based treatment objectives for managing sleep apnea in hospitalized patients, considering acuity, safety, and continuity of care.

Michelle F. Zetoony-Nudell, DO, FACOI, Clinician and Owner, DO Sleep Solutions, Inc

Learning Objectives:

• Distinguish cancer-related cachexia from malnutrition as an etiology of weight loss in oncology patients to support appropriate evaluation and patient counseling.
• Identify the clinical features, diagnostic criteria, and staging of cachexia in internal medicine patients.
• Identify evidence-based management strategies for cancer-related cachexia, including nutritional interventions, pharmacologic therapies, and symptom-directed care.

Deborah Humphrey, DO, Associate Professor, University of South Florida/Morsani College of Medicine

Learning Objectives:

• Apply 2026 acute ischemic stroke (AIS) updates: prehospital triage, thrombolysis, and thrombectomy selection
• Implement 2021 secondary prevention strategies (antithrombotics, lipids, BP, carotids, cardioembolic sources)
• Translate 2024 primary prevention guidance into clinic workflows (Life’s Essential 8, sex-specific risk, SDOH)

Vikranth Gongidi, DO, FACOI, Cardiologist, Premier Cardiology of Vero Beach

Learning Objectives:

• Identify clinical features, diagnostic strategies, and risk factors associated with the development and progression of atrial fibrillation.
• Apply contemporary guideline-directed approaches to anticoagulation, rate control, and rhythm control in patients with atrial fibrillation.
• Recognize patient-specific factors that influence treatment selection, including AF burden, comorbid conditions, and indications for early specialty referral.

Chad A. Link, DO, FACC, FACOI, Cardiologist, University of Michigan Health- Sparrow